Patent · US Active

Hepcidin analogues and uses thereof

US10442846B2 · kind B2 · utility

15Cited by
28References
19Claims
0Family size

Assignee

Inventors

Key dates

Filing dateJul 17, 2018
Grant dateOct 15, 2019
Priority date
Expiry dateJul 17, 2038

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61K38/00
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The present invention relates, inter alia, to certain hepcidin peptide analogs, including peptides and dimers thereof, and to the use of the peptides and peptide dimers in the treatment and/or prevention of a variety of diseases, conditions or disorders, including treatment and/or prevention of iron overload diseases, which include hereditary hemochromatosis and iron-loading anemias, and other conditions and disorders described herein.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.